2010 Medical Design Excellence Award for bioMérieux’s PREVI Isola
The fully automated system is capable of processing up to 300 plates per hour, standardising routine agar plate inoculation and offering fast turnaround times with improved traceability. Colony isolation is maximised and cross-contamination eliminated, streamlining laboratory workflows to save time and free staff for other tasks.
bioMérieux’s Chief Executive Officer, Stéphane Bancel, said “bioMérieux is proud to see the PREVI Isola recognised by this prestigious award. I would like to thank our partners at LBT Innovations and Invetech, and our teams at bioMérieux, for making it possible for us to bring this visionary solution to our customers. As the World leader in microbiology, bioMérieux is driving microbiology lab automation, with new systems and IT solutions for rapid time to results, ensuring rapid time to therapy for patients. Our goal is to transform microbiology to better serve our customers, clinicians and their patients.”
Most read news
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.